NASDAQ:HSIC - Henry Schein Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $61.80
  • Forecasted Upside: -2.95 %
  • Number of Analysts: 11
  • Breakdown:
  • 3 Sell Ratings
  • 5 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$63.68
▼ -0.45 (-0.70%)
1 month | 3 months | 12 months
Get New Henry Schein Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HSIC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HSIC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$61.80
▼ -2.95% Downside Potential
This price target is based on 11 analysts offering 12 month price targets for Henry Schein in the last 3 months. The average price target is $61.80, with a high forecast of $72.00 and a low forecast of $50.00. The average price target represents a -2.95% upside from the last price of $63.68.
Hold
The current consensus among 11 polled investment analysts is to hold stock in Henry Schein. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 4 sell ratings
6/7/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 4 sell ratings
9/5/2019
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 3 sell ratings
12/4/2019
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 2 sell ratings
3/3/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 3 sell ratings
6/1/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 3 sell ratings
8/30/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 3 sell ratings
10/29/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 3 sell ratings
11/28/2020

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 3 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2020Barrington ResearchUpgradeMarket Perform ➝ Outperform$72.00Medium
i
Rating by M. Petusky at Barrington Research
5/7/2020UBS GroupLower Price TargetSell$60.00 ➝ $50.00High
i
5/6/2020Robert W. BairdBoost Price TargetNeutral$58.00 ➝ $60.00Low
i
5/6/2020Barrington ResearchDowngradeOutperform ➝ Market PerformMedium
i
Rating by M. Petusky at Barrington Research
5/5/2020CfraLower Price TargetHold$69.00 ➝ $60.00Medium
i
4/19/2020Credit Suisse GroupReiterated RatingHold$59.00Low
i
4/7/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy$64.00 ➝ $59.00Low
i
4/2/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$68.00Medium
i
3/31/2020BarclaysLower Price TargetEqual Weight$58.00 ➝ $57.00Medium
i
3/20/2020BarclaysReiterated RatingHold$58.00High
i
2/24/2020JPMorgan Chase & Co.Boost Price TargetNeutral$66.00 ➝ $68.00Medium
i
1/9/2020Bank of AmericaDowngradeNeutral ➝ Underperform$65.00High
i
1/3/2020Evercore ISIDowngradeIn-Line ➝ UnderperformLow
i
Rating by Ross Muken at Evercore ISI
1/2/2020Robert W. BairdDowngradeOutperform ➝ NeutralLow
i
12/3/2019Bank of AmericaBoost Price TargetNeutral$69.00 ➝ $71.00Low
i
11/11/2019Piper Jaffray CompaniesBoost Price TargetOverweight$72.00 ➝ $80.00Low
i
11/6/2019Barrington ResearchReiterated RatingBuy$75.00Low
i
11/1/2019Cleveland ResearchReiterated RatingHoldN/A
i
Rating by Rob Eich at Cleveland Research
8/7/2019Barrington ResearchReiterated RatingBuy$75.00Medium
i
8/7/2019William BlairDowngradeOutperform ➝ Market PerformHigh
i
Rating by J. Kreger at William Blair
5/30/2019Wolfe ResearchInitiated CoverageUnderperform ➝ UnderperformLow
i
5/15/2019SVB LeerinkReiterated RatingOutperform ➝ Market Perform$75.00 ➝ $70.00Low
i
Rating by D. Larsen at SVB Leerink LLC
5/8/2019Barrington ResearchBoost Price TargetOutperform$72.00 ➝ $75.00Medium
i
5/8/2019Craig HallumReiterated RatingBuy$72.00 ➝ $77.00High
i
5/2/2019Cleveland ResearchReiterated RatingHoldLow
i
Rating by Rob Eich at Cleveland Research
4/17/2019GuggenheimInitiated CoverageBuy ➝ Buy$72.00Medium
i
3/25/2019Robert W. BairdReiterated RatingNeutralMedium
i
2/21/2019Royal Bank of CanadaLower Price TargetAverage ➝ Sector Perform$62.00Medium
i
2/21/2019BarclaysLower Price TargetEqual Weight ➝ Equal Weight$73.00 ➝ $63.00Low
i
2/21/2019Barrington ResearchReiterated RatingBuy$72.00Low
i
2/19/2019Craig HallumLower Price TargetBuy$96.00 ➝ $72.00Low
i
2/12/2019Royal Bank of CanadaLower Price TargetPositive ➝ Sector Perform$69.00Low
i
1/17/2019UBS GroupInitiated CoverageSell ➝ Sell$73.00Medium
i
1/3/2019Evercore ISIDowngradeIn-Line ➝ Underperform$76.39Medium
i
1/2/2019Robert W. BairdDowngradeOutperform ➝ Neutral$76.60High
i
11/29/2018Piper Jaffray CompaniesReiterated RatingOverweight$96.00Low
i
11/8/2018Barrington ResearchBoost Price TargetReduce ➝ Outperform$92.00 ➝ $96.00Medium
i
10/25/2018Edward JonesDowngradeHold ➝ SellLow
i
10/20/2018The Goldman Sachs GroupInitiated CoverageHold$78.00Low
i
Rating by Nathan Rich at The Goldman Sachs Group, Inc.
10/19/2018The Goldman Sachs GroupReiterated RatingNeutral ➝ NeutralLow
i
10/9/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$65.00 ➝ $66.00Low
i
10/4/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$90.00 ➝ $95.00Low
i
9/24/2018Cleveland ResearchReiterated RatingHoldLow
i
Rating by Rob Eich at Cleveland Research
8/7/2018SVB LeerinkSet Price TargetBuy$100.00Low
i
Rating by David Larsen at SVB Leerink LLC
8/7/2018Barrington ResearchReiterated RatingBuy$92.00Low
i
Rating by M. Petusky at Barrington Research
8/7/2018Craig HallumBoost Price TargetBuy$83.00 ➝ $96.00Low
i
8/7/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$83.00 ➝ $90.00Low
i
8/7/2018Stifel NicolausBoost Price TargetHold ➝ Hold$76.00 ➝ $81.00High
i
5/10/2018Barrington ResearchLower Price TargetOutperform$88.00Low
i
Rating by M. Petusky at Barrington Research
5/9/2018BarclaysReiterated RatingHold$73.00Low
i
4/24/2018Northcoast ResearchSet Price TargetBuy$102.00Low
i
Rating by Edwin Snyder at Northcoast Research
4/24/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$79.00 ➝ $82.00High
i
4/24/2018The Goldman Sachs GroupDowngradeBuy ➝ NeutralHigh
i
4/4/2018SVB LeerinkUpgradeMarket Perform ➝ Outperform$75.00High
i
Rating by David Larsen at SVB Leerink LLC
3/8/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$71.00Low
i
2/27/2018Bank of AmericaInitiated CoverageNeutral ➝ Neutral$76.00Low
i
2/21/2018Barrington ResearchReiterated RatingOutperformLow
i
Rating by M. Petusky at Barrington Research
2/21/2018SVB LeerinkSet Price TargetMarket Perform ➝ Hold$77.00 ➝ $75.00Low
i
Rating by David Larsen at SVB Leerink LLC
2/15/2018JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Neutral$79.00 ➝ $77.00Low
i
2/13/2018SVB LeerinkReiterated RatingHoldHigh
i
Rating by David Larsen at SVB Leerink LLC
1/4/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$81.00Medium
i
12/27/2017Piper Jaffray CompaniesReiterated RatingBuy$78.00Low
i
12/8/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$79.00Low
i
12/6/2017Morgan StanleyDowngradeEqual Weight ➝ Underweight$88.00High
i
11/28/2017Credit Suisse GroupReiterated RatingNeutral$87.50 ➝ $80.00Low
i
11/28/2017StephensInitiated CoverageEqual ➝ Equal Weight$76.00Low
i
11/7/2017Jefferies Financial GroupLower Price TargetHold$89.00 ➝ $74.00N/A
i
11/7/2017SVB LeerinkReiterated RatingMarket Perform$87.50 ➝ $77.00N/A
i
11/7/2017Stifel NicolausLower Price TargetHold ➝ Hold$89.00 ➝ $77.00N/A
i
11/7/2017Craig HallumUpgradeHold ➝ BuyN/A
i
11/7/2017Royal Bank of CanadaLower Price TargetSector Perform ➝ Sector Perform$91.00 ➝ $82.00N/A
i
10/20/2017Jefferies Financial GroupReiterated RatingHold$89.00N/A
i
10/19/2017Robert W. BairdSet Price TargetBuy$95.00N/A
i
Rating by Jeff Johnson at Robert W. Baird
10/19/2017Stifel NicolausReiterated RatingHold$89.00N/A
i
9/28/2017Jefferies Financial GroupReiterated RatingHold$88.50Low
i
9/21/2017Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$88.00Low
i
9/19/2017Royal Bank of CanadaInitiated CoverageSector Perform ➝ Sector Perform$91.00High
i
9/15/2017UBS GroupReiterated RatingBuyN/A
i
9/15/2017Piper Jaffray CompaniesUpgradeNeutral ➝ OverweightLow
i
8/29/2017Credit Suisse GroupReiterated RatingHold$87.50Low
i
8/7/2017Northcoast ResearchUpgradeNeutral ➝ Buy$109.00High
i
Rating by E. Snyder at Northcoast Research
7/21/2017Jefferies Financial GroupReiterated RatingHold$88.50Low
i
7/13/2017Credit Suisse GroupReiterated RatingHold$80.00 ➝ $80.00Low
i
7/6/2017Stifel NicolausReiterated RatingHoldLow
i
6/12/2017Piper Jaffray CompaniesInitiated CoverageNeutral ➝ Neutral$100.00Low
i
5/10/2017Barrington ResearchBoost Price TargetOutperform ➝ Outperform$98.00 ➝ $99.00Low
i
5/10/2017Stifel NicolausBoost Price TargetHold ➝ Hold$87.00 ➝ $89.00Low
i
4/11/2017Craig HallumInitiated CoverageHoldLow
i
3/15/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$87.00Low
i
2/28/2017Jefferies Financial GroupReiterated RatingHold$82.50N/A
i
2/22/2017SVB LeerinkSet Price TargetHold$91.50N/A
i
Rating by David Larsen at SVB Leerink LLC
2/22/2017Barrington ResearchReiterated RatingOutperform ➝ Outperform$92.50 ➝ $98.00N/A
i
2/21/2017Evercore ISIBoost Price TargetHold$80.00 ➝ $89.00N/A
i
1/10/2017GabelliUpgradeHold ➝ Buy$104.00N/A
i
Rating by K. Kedra at Gabelli
1/3/2017Robert W. BairdUpgradeNeutral ➝ Outperform$82.00 ➝ $85.00N/A
i
12/6/2016Northcoast ResearchDowngradeBuy ➝ NeutralN/A
i
Rating by E. Snyder at Northcoast Research
11/3/2016JPMorgan Chase & Co.Reiterated RatingHold$81.50N/A
i
11/3/2016SVB LeerinkReiterated RatingHoldN/A
i
10/14/2016Robert W. BairdDowngradeOutperform ➝ Neutral$88.00 ➝ $82.00N/A
i
10/11/2016The Goldman Sachs GroupUpgradeNeutral ➝ Buy$92.50N/A
i
10/5/2016UBS GroupInitiated CoverageBuy$93.00N/A
i
10/4/2016Robert W. BairdReiterated RatingOutperform$87.50 ➝ $88.00N/A
i
9/12/2016Bank of AmericaInitiated CoverageBuy$92.50N/A
i
6/4/2016Credit Suisse GroupReiterated RatingHoldN/A
i
Rating by Robert Willoughby at Credit Suisse Group AG
5/5/2016SVB LeerinkReiterated RatingHoldN/A
i
5/4/2016Barrington ResearchReiterated RatingOutperform$91.00 ➝ $94.00N/A
i
3/16/2016Robert W. BairdBoost Price Target$83.50 ➝ $87.50N/A
i
3/15/2016Credit Suisse GroupInitiated CoverageNeutral$85.00N/A
i
3/1/2016Barrington ResearchUpgradeMarket Perform ➝ Outperform$91.00N/A
i
Rating by M. Petusky at Barrington Research
2/11/2016Piper Jaffray CompaniesReiterated RatingNeutral$79.00 ➝ $79.50N/A
i
2/11/2016SVB LeerinkBoost Price TargetMarket Perform$80.00 ➝ $85.00N/A
i
2/11/2016The Goldman Sachs GroupBoost Price TargetNeutral$74.50 ➝ $77.00N/A
i
12/3/2015Evercore ISIReiterated RatingBuy$77.50 ➝ $77.00N/A
i
(Data available from 11/28/2015 forward)
Henry Schein logo
Henry Schein, Inc., a solutions company for health care professionals, provides health care products and services to office-based dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Read More

Today's Range

Now: $63.68
$63.43
$64.70

50 Day Range

MA: $63.41
$59.66
$68.08

52 Week Range

Now: $63.68
$41.85
$73.99

Volume

292,167 shs

Average Volume

1,499,935 shs

Market Capitalization

$9.09 billion

P/E Ratio

15.68

Dividend Yield

N/A

Beta

0.92